IL6 and cancer: For decades, interleukin 6 (IL‐6), procalcitonin (PCT), and C‐reactive protein (CRP) have been widely investigated to identify pathogenic bacteria, evaluate the severity of infection, and predict adverse outcomes in cancer patients.10, 11, 12, 13, 14